This article was originally published in SRA
EU drafts guideline on new uses for well-established substances
You may also be interested in...
Sensyne obtained UK regulatory approval for its SYNE-COV machine learning algorithm to assess the long-term risks of COVID-19.
While the EU attempts to accelerate the pace of its unified approach to vaccine roll-out, some eastern European countries are taking their own decisions.
New medicines under evaluation at the European Medicines Agency.